Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseases
Abstract Background Rare diseases affect few people, but collectively they affect a substantial proportion of the population. Limited treatment options and the additional challenges of securing public funding make reimbursement decision making particularly complex, mainly due to the inherent evidenc...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2025-12-01
|
| Ráidu: | Orphanet Journal of Rare Diseases |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s13023-025-04141-0 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
